Approval · Notice of Compliance 19002 · 2017
SIMBRINZA: Notice of Compliance 19002
Issued February 23, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19002
- Date
- February 23, 2017
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIMBRINZA | 02435411 | Marketed |
Medicinal ingredients
- BRIMONIDINE TARTRATE 0.2 PER
- BRINZOLAMIDE 1 PER